TargetGene Biotechnologies

Genome Editing for Living Organisms

Health Tech & Life Sciences
Active
Series B Rehovot, Israel Founded 2012
Last updated 2026-06-18
Total raised
$9.2M
Last: 2016-06
Stage
Series B
Founded
2012
Headcount
7
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

TargetGene Biotechnologies is an innovative and agile biotechnology company in its development stage and poised for expansion. The companys R&D is centered around creating efficient and extremely specific DNA editing solutions in living organisms. Through its patented and patent-pending TGEE (genome editing engine) platform, TargetGene has developed RNA-guided gene targeting. The company aims to implement the TGEE platform for human gene therapy with a focus on inherited diseases and cell-based immunotherapy.

Funding history · 2 rounds · $9.2M total

2013-01
$2.5M

Q&A

What is TargetGene Biotechnologies' primary focus?
TargetGene Biotechnologies focuses on creating efficient and specific DNA editing solutions in living organisms, with R&D centered on its patented and patent-pending TGEE (genome editing engine) platform.
When was TargetGene Biotechnologies founded?
TargetGene Biotechnologies was founded in October 2012.
What is the total amount of funding TargetGene Biotechnologies has raised?
TargetGene Biotechnologies has raised a total of $9,200,000 USD.
Which investors participated in TargetGene Biotechnologies' June 2016 funding round?
In June 2016, Monsanto participated in a funding round for TargetGene Biotechnologies.
What is TargetGene Biotechnologies' current employee count?
TargetGene Biotechnologies has 1-10 employees.
What is the primary sector of TargetGene Biotechnologies?
TargetGene Biotechnologies operates in the Health Tech & Life Sciences sector.
What is the company's strategic goal for its TGEE platform?
TargetGene Biotechnologies aims to implement its TGEE platform for human gene therapy, specifically focusing on inherited diseases and cell-based immunotherapy.
Does TargetGene Biotechnologies hold any patents?
Yes, TargetGene Biotechnologies holds patents and has patent-pending technology.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & COO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B

Highlights

1 PatentsVerified

Tags

laboratoriesmedical-technologiesbiotechnologygenomicsgenetic-engineeringacademiageneticspatent-pending
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)